Literature DB >> 14206916

PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CARCINOMA OF THE LUNG.

J N BICKERS.   

Abstract

Keywords:  ANTINEOPLASTIC AGENTS; CARCINOMA, EPIDERMOID; DRUG THERAPY; LUNG NEOPLASMS; NEOPLASM METASTASIS; TOXICOLOGIC REPORT; UREA

Mesh：

Substances：

Year:  1964        PMID： 14206916

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  2 in total

1.  Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair. A phase II study in non-small-cell lung cancer.

Authors:  B M Cantwell; D Veale; C Rivett; S Ghani; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?

Authors:  Mukundan Baskar Mannargudi; Subrata Deb
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-17       Impact factor: 4.322
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.